| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $80.1M | — | -50.2% |
| Cost of Revenue | $74.5M | — | -50.4% |
| Gross Profit | $5.6M | — | -47.1% |
| R&D Expense | $886K | — | -13.1% |
| SG&A Expense | $6.1M | — | -14.9% |
| Operating Income | -$9.0M | — | +21.7% |
| Pre-tax Income | -$10.1M | — | +32.6% |
| Income Tax | $16K | — | -56.8% |
| Net Income | -$10.1M | — | +32.7% |
| EPS (Basic) | -$0.22 | — | +60.0% |
| EPS (Diluted) | -$0.22 | — | +60.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.8M | +53.8% | +32.4% |
| Accounts Receivable | $8.2M | +3.5% | +30.6% |
| Inventory | $74.7M | -20.4% | -64.6% |
| Current Assets | $127.1M | -3.5% | -50.2% |
| Total Assets | $149.8M | -3.2% | -45.4% |
| Current Liabilities | $76.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $9.0M | — | +188.9% |
| Capital Expenditures | $19K | — | -98.1% |
| Investing Cash Flow | -$2K | — | +99.8% |
| Financing Cash Flow | $4.4M | — | +116.5% |
| Free Cash Flow | $9.0M | — | +180.8% |
| -66.2% |
| Total Liabilities | $103.9M | -10.8% | -56.7% |
| Stockholders' Equity | $45.8M | +19.9% | +34.0% |